2018 Speakers

Aleksandra J. Poole is a vetted professional with over 18 years of research experience and over 10 years of industry and management experience in cancer and stem biology, translational research and biomarker discovery. Her research background is diverse but mainly focuses on translating preclinical work into clinical cancer treatments and other cellular regenerative medicine therapies.…

With over fourteen years’ experience, Vlad is an accomplished executive, specialized in the aesthetic energy device field. With an AB Biology degree from Brown University and having attended Johns Hopkins University Graduate School of Arts and Sciences, he has strong expertise including general management with full P&L responsibility and business development, as well as clinical…

After studying economics at Kings College in Cambridge, Chris pursued a career in investment banking working for JPM Morgan and Bank of America as a pharmaceutical analyst. In 2011, he left banking to join Sinclair as CEO and has driven the evolution of the company from a medicinal dermatology specialist to become a leading pure-play…

Former Chairman and CEO of Andrew Technologies LLC from 2011 to 2017. In the past, Mr. Albright was President of the topical aesthetic division at Syneron Medical Ltd. and before that Head of North American marketing at Nobel Biocare. From 2000 to 2008, Mr. Albright was VP BOTOX Global Strategic Marketing at Allergan, where he…

Jeffrey Nugent joined Sientra in 2014 as a board member, prior to becoming the Chairman and CEO in 2015. Mr. Nugent’s experience includes serving as the CEO and Worldwide President of Neutrogena, where he led the acquisition by Johnson & Johnson. Neutrogena is regarded as one of the most successful acquisitions in J&J history. Following…

Mr. Plants founded Voce Capital Management LLC, a value-oriented, employee-owned investment advisor, in 2011. His two decades of experience prior to Voce featured leadership roles from Wall Street to Sand Hill Road, including executive positions in the mergers and acquisitions groups at Goldman, Sachs & Co. and JPMorgan. His prior career spans dozens of successful…

Brad Hauser currently serves as President and Chief Executive Officer of Soliton within Allergan Aesthetics, an AbbVie company. Mr. Hauser served as President and CEO of Soliton, Inc. from November 2020 until it was acquired by Allergan Aesthetics in December 2021.  Previously, he served as  the Vice President, R&D and General Manager for CoolSculpting at…

Lori Fontaine is Vice President of Clinical Affairs at Hologic, Inc. and is responsible for driving and executing global clinical research and medical education strategies to support product innovation and development. Ms. Fontaine has more than 25 years of eclectic healthcare experience in clinical research, medical education, information technology, consulting, administration and direct patient care.…

Kellie Lao oversees consumer marketing and acquisition for Allergan’s facial injectables flagship brands: BOTOX® Cosmetic, JUVEDERM® collection of fillers and KYBELLA®. Her expertise includes product launches, product lifecycle planning, branding, market research, creative strategy, multi-channel marketing, advertising, public relations and media planning. Ms. Lao holds a Master’s degree in Communication Management from University of Southern…

Marc Toulemonde is the Group President of L’Oréal USA’s Active Cosmetics Division; a position he has held since 2014. In his current role, Mr. Toulemonde oversees the division’s business units, innovations, strategies, growth and positioning of 7 brands like SkinCeuticals, La Roche-Posay, Vichy and Dermablend. In 2017, he oversaw the acquisition of CeraVe, Ambi and…